Explore 4 therapeutics startups that raised post-ipo secondary funding. Access verified founder contact information and fundraising data.
Get founder emails, funding data, and company details in one CSV
Thalia Therapeutics is a drug reformulation company.
Nuvalent is a biopharmaceutical company that develops targeted therapies for cancer by designing small-molecule medicines.
Molecure is an innovative biopharmaceutical company that specializes in discovery, development, and commercialization of novel therapeutics.
Werewolf Therapeutics operates as an oncology biotherapeutics company.
Get verified founder emails, funding details, and company data for 4 post-ipo secondary therapeutics companies.
Get Started - Access Contact InformationJoin thousands of sales teams, investors, and service providers using VCBacked